TSXV:CLAS.H - Post Discussion
Post by
Red~One on Apr 24, 2022 7:30pm
Other N.O. News
Beyond Air® to Participate in Three Upcoming Medical Conferences
GARDEN CITY, N.Y., April 18, 2022 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension and, through its affiliate Beyond Cancer, ultra-high concentration nitric oxide (UNO) for the treatment of solid tumors, today announced that the Company is scheduled to present new data at three upcoming medical conferences.
Be the first to comment on this post